Company intelligence / Profile preview

LTL Pharma

Tokyo/Shinjuku-ku/Nishi-Shinjuku area, Tokyo-to/Tokyo Prefecture, Japanltl-pharma.com ↗

Ownership: Private
Development stage: Commercial

Overview

LTL Pharma specializes in the stable supply of long-listed ethical drugs ("Long-life Medicines") that have established safety and efficacy profiles. The company acquires mature brands from major pharma companies to ensure continued access for patients. Recent clinical results are not typically generated by the company itself as it focuses on marketed products with established data.

Therapeutic areas: EndocrinologyImmunologyPsychiatryCardiovascularInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Biotech

Drug pipeline

1 asset

Dellegra

Partnerships

Partnerships with local distributors in at least sixteen countries for overseas businessproduct acquisition partnerships with Astellas Pharma Inc.product acquisition partnerships with Chugai Pharmaceutical/Roche for specific assets such as Oxarol Injection

Beyond the preview

Go deeper on LTL Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LTL Pharma.

Explore the full profile